Ledger.Open graph →
SEC Form D · filed November 7, 2022

Taysha Gene Therapies, Inc

Offering
$30.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DALLAS, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Laura B. Sepp-Lorenzino · Dallas, TXDirectorRa Session Ii · Dallas, TXExec · DirectorKathleen B. Reape · Dallas, TXDirectorSukumar B. Nagendran · Dallas, TXDirectorKamran B. Alam · Dallas, TXExecPhillip B. Donenberg · BUFFALO GROVE, ILDirectorPaul B. Manning · Berkeley, CADirectorSean P. Nolan · Morrisville, NCDirectorSuyash B. Prasad · Dallas, TXExecLaura B. Sepp-Lorenzino · Dallas, TXDirectorRa Session Ii · Dallas, TXExec · DirectorKathleen B. Reape · Dallas, TXDirectorKamran B. Alam · Dallas, TXExecPhillip B. Donenberg · Dallas, TXDirectorPaul B. Manning · Berkeley, CADirectorSean P. Nolan · Morrisville, NCDirectorSuyash B. Prasad · Dallas, TXExecSukumar B. Nagendran · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗